SpringWorks Therapeutics, Inc. SWTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

57/100

4/7 Pass

SharesGrow Intrinsic Value

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Balance sheet is a point-in-time snapshot. TTM shows the most recent available quarter.

Metric	Latest Quarter (2025-03)
Total Assets	$505.36M
Total Liabilities	$87.96M
Total Debt	$7.39M
Cash & Investments	$287.87M
Total Stockholders Equity	$417.4M

People Also View

RVMD

Revolution Medicines, Inc.

$152.54

+3.76%

BPMC

Blueprint Medicines Corporation

$129.46

+0.14%

CERE

Cerevel Therapeutics Holdings, Inc.

$44.96

+0.74%

KYMR

Kymera Therapeutics, Inc.

$89.00

-0.96%

APLS

Apellis Pharmaceuticals, Inc.

$40.85

-0.01%

TERN

Terns Pharmaceuticals, Inc.

$52.71

+0.06%

MRTX

Mirati Therapeutics, Inc.

$58.70

-0.17%

RLAY

Relay Therapeutics, Inc.

$15.49

+5.02%

SpringWorks Therapeutics, Inc. SWTX NASDAQ

People Also View

Get Undervalued Stock Alerts